Omagine (OTCMKTS:OMAG) Stock Crosses Below 50-Day Moving Average – Should You Sell?

Omagine Inc (OTCMKTS:OMAGGet Free Report)’s stock price crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.01 and traded as low as $0.0017. Omagine shares last traded at $0.0017, with a volume of 3,400 shares trading hands.

Omagine Trading Up 6.2%

The stock’s fifty day moving average is $0.01 and its 200-day moving average is $0.01.

Omagine Company Profile

(Get Free Report)

Omagine, Inc is a development‐stage medical technology company focused on the research, development and commercialization of advanced regenerative wound care products. The company’s proprietary platform is designed to deliver an in situ polymerizing hydrogel scaffold directly at the wound site, where it aims to mimic the body’s natural extracellular matrix and promote accelerated healing of both acute and chronic wounds.

Omagine’s lead product candidate, Regenerative Tissue Replacement (RTR), employs a bioactive formulation that conforms precisely to complex wound geometries and supports key biological processes such as cell migration, angiogenesis and tissue regeneration.

Featured Stories

Receive News & Ratings for Omagine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omagine and related companies with MarketBeat.com's FREE daily email newsletter.